Suspected side effect from a medicine - how to report

The Medicines and Healthcare products Regulatory Agency (MHRA) “Yellow Card Scheme” is the UK system for collecting and monitoring information on suspected safety concerns or incidents involving side effects to medicines (also known as adverse drug reactions or ADRs) and medical devices. 

The Scheme is run by the MHRA and currently relies on voluntary reporting of suspected ADRs by health professionals and patients. It purpose is to provide an early warning that the safety of a product may require further investigation.

The joint RCPCH and Neonatal and Paediatric Pharmacists Group Medicines Committee advises accordance to the best practice guidance set out within the Yellow Card Scheme.